These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 15514730

  • 1. Tartrate-resistant acid phosphatase as a marker of bone metastases in patients with breast cancer and prostate cancer.
    Lyubimova NV, Pashkov MV, Tyulyandin SA, Gol'dberg VE, Kushlinskii NE.
    Bull Exp Biol Med; 2004 Jul; 138(1):77-9. PubMed ID: 15514730
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of tartrate-resistant acid phosphatase (TRAP) 5b as serum marker of bone metastases in human breast cancer.
    Capeller B, Caffier H, Sütterlin MW, Dietl J.
    Anticancer Res; 2003 Jul; 23(2A):1011-5. PubMed ID: 12820340
    [Abstract] [Full Text] [Related]

  • 3. Tartrate-resistant acid phosphatase 5B is a specific and sensitive marker of bone resorption.
    Halleen JM.
    Anticancer Res; 2003 Jul; 23(2A):1027-9. PubMed ID: 12820342
    [Abstract] [Full Text] [Related]

  • 4. [TARTRAT-RESISTANT ACID PHOSPHATASE AS BONE'S RESORBTION MARKER IN PATIENTS WITH BONE METASTASES].
    Dedkov AG, Boychuk SI, Stakhovsky EA, Kukushkina MN, Kovalchuk PA.
    Lik Sprava; 2015 Jul; (5-6):104-9. PubMed ID: 27089726
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Serum tartrate-resistant acid phosphatase 5b (TRACP 5b) as a marker of skeletal changes in prostate cancer.
    Salminen E, Ala-Houhala M, Korpela J, Varpula M, Tiitinen SL, Halleen JM, Väänänen HK.
    Acta Oncol; 2005 Jul; 44(7):742-7. PubMed ID: 16227166
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Tartrate-resistant acid phosphatase isoform 5b: a novel serum marker for monitoring bone disease in multiple myeloma.
    Terpos E, de la Fuente J, Szydlo R, Hatjiharissi E, Viniou N, Meletis J, Yataganas X, Goldman JM, Rahemtulla A.
    Int J Cancer; 2003 Sep 01; 106(3):455-7. PubMed ID: 12845688
    [Abstract] [Full Text] [Related]

  • 14. Serum levels of tartrate-resistant acid phosphatase-5b in breast cancer patients treated with pamidronate.
    Martinetti A, Seregni E, Ripamonti C, Ferrari L, De Conno F, Miceli R, Pallotti F, Coliva A, Biancolini D, Bombardieri E.
    Int J Biol Markers; 2002 Sep 01; 17(4):253-8. PubMed ID: 12521129
    [Abstract] [Full Text] [Related]

  • 15. Tartrate-resistant acid phosphatase 5b as serum marker of bone metabolism in cancer patients.
    Mose S, Menzel C, Kurth AA, Obert K, Breidert I, Borowsky K, Böttcher HD.
    Anticancer Res; 2003 Sep 01; 23(3C):2783-8. PubMed ID: 12926113
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of tartrate-resistant acid phosphatase (TRACP) 5b as bone resorption marker in irradiated bone metastases.
    Mose S, Menzel C, Kurth AA, Obert K, Ramm U, Eberlein K, Boettcher HD, Pichlmeier U.
    Anticancer Res; 2005 Sep 01; 25(6C):4639-45. PubMed ID: 16334155
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Value of TRAcP 5b as a diagnostic marker for detection of bone metastases in patients with breast cancer.
    Hung MJ, Oremek GM.
    Eur J Gynaecol Oncol; 2011 Sep 01; 32(6):615-8. PubMed ID: 22335021
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.